Stock listing
OTC:BMKDF BioMark Diagnostics, Inc. Stock
US listing (OTC) of BioMark Diagnostics, Inc. · home listing CSE:BUX
Follow BioMark Diagnostics, Inc. into a list and get an email when it puts out news.
Share price · OTC:BMKDF
$0.336 USD +0.007 (+2.1%)
Close on Oct 27, 2026
- Day range
- $0.318 – $0.336 USDOct 27, 2026
- Volume
- 1,200 sharesOct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:BUX · Home | $0.47 CAD | +0.02 (+4.4%) | 10,500 | $0.44 | $0.47 | $0.41 | $0.45 | Close on Oct 30, 2026 |
| OTC:BMKDF | $0.336 USD | +0.007 (+2.1%) | 1,200 | $0.325 | $0.336 | $0.318 | $0.329 | Close on Oct 27, 2026 |
| Frankfurt:20B | €0.266 EUR | -0.006 (-2.2%) | — | €0.264 | €0.266 | €0.264 | €0.272 | Close on Oct 30, 2026 |
- Ticker
- OTC:BMKDF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Sep 21, 2026
BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences
Latest news
Decks
Investor Presentation (September 2025)
Investor deck · 23 slides · September 2025
Investor Presentation (June 2019)
Investor deck · 32 slides · June 2019
BioMark Diagnostics, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 11 in the last 12 months · 22 in all · newest Sep 21, 2026 · oldest 2025
- Decks
- 2 decks · latest September 2025
Where BioMark Diagnostics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:BUX · Home listing | CSE | Canada | CAD |
| OTC:BMKDF · This page | OTC | United States | USD |
| LS Exchange:A12EKB | LS Exchange | Germany | EUR |
| Lang & Schwarz:A12EKB | Lang & Schwarz | Germany | EUR |
| Cboe Canada:BUX | Cboe Canada | Canada | CAD |
| Frankfurt:20B | Frankfurt | Germany | EUR |
| Stuttgart:20B | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about BioMark Diagnostics, Inc.